CRTAM inhibition mitigates toxicity of immune checkpoint inhibitors without antitumor efficacy trade-off.

Saved in:
Bibliographic Details
Title: CRTAM inhibition mitigates toxicity of immune checkpoint inhibitors without antitumor efficacy trade-off.
Authors: Ma SC; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Rong ZX; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Xu ZP; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Zhang YP; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Zhuang KM; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Sun H; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China., Cao CH; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Wu ZN; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Zhang HP; School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China., Zuo Q; Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Lin JR; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.; Department of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, China., Cheng JX; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Qu HT; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Han DD; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Wei W; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.; Department of Oncology, Xiangyang Central Hospital, Hubei University of Arts and Science, Xiangyang, China., Liu K; Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.; Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Cai XT; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Guo ZQ; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Bai X; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Liu L; Department of Health Management, Nanfang Hospital, Southern Medical University, Guangzhou, China. liuli@i.smu.edu.cn., Wu DH; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China. 18602062748@163.com., Dong ZY; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China. dongzy1317@foxmail.com.
Source: Nature cancer [Nat Cancer] 2026 Apr; Vol. 7 (4), pp. 650-666. Date of Electronic Publication: 2026 Mar 05.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2662-1347
DOI:10.1038/s43018-026-01135-0